The Ministry of Health to regulate drug business bribery black list companies for two years

Wang Zhooming Zhangxuyue After the NDRC, the Ministry of Health also erected a crackdown on high drug prices banner. June 30, the Ministry of Health issued a notice to further deepen the management of drug purchase and sale in the field of commercial bribery work. Although this document by the industry known as "not much new", but the general manager of a pharmaceutical company in Beijing Chen Chenglong does to see the clue: "Can see that the health department's governance will be very large." Every time the storm will have a group of enterprises involved, now insecure. "This is the second time in a row in just one months, the Ministry of Health has declared the drug business bribery."　　May 28, the Ministry of Health in order to control the high price of drugs proposed five norms, including commercial bribery will be "always maintain high pressure posture" argument.　　The incident may have come from the recent spate of "bad events": At the end of April, Hunan exposed a huge price of asparagus film incident; May 30, a Ningbo First hospital "rebate list" exposure; June 3, the former president of Jiangsu Changzhou Seventh People's Hospital for bribery 620,000 was sentenced to 7 years; June 17, the new health care drug surprise increase was revealed.　　And at the level of the state Drug Administration, rumors that the state Drug Administration deputy Director of Zhang Jingli for accepting corporate bribery is double regulation; Before this, the National Drug Administration Bureau of Drug Registration Division, the Department of Biological Products Weiliang, such as five Drug Administration officials have been arrested.　　The frequent cases of commercial bribery in medicine may be the original intention of this round of governance storm. Provinces or the establishment of bribery "blacklist" Ministry of Health regulation of commercial bribery documents, said: "From the recent period of detection and investigation of commercial bribery, drug purchase and sale in the field of commercial bribery in some places and units appeared rebound." "This indicates that the Ministry of Health has mastered a number of business cases involving commercial bribery.　　"The industry told this newspaper, in the series of measures to regulate commercial bribery after implementation, not to rule out the possibility of more and more enterprises involved." However, an official of the Ministry of Health July 1 in an interview with this reporter said: "Just said recently found more commercial bribery cases, and can not say that the phenomenon of commercial bribery more and more serious." "The Ministry of Health does not have a so-called ' blacklist '. "The Ministry of Health officials said that the main force for the prosecution of commercial bribery is subordinate provincial health departments," specific to the enterprise or personnel of the investigation and enforcement departments around the work, the principle is where found on where to investigate, will not involve other regions. The Ministry of Health is only responsible for external briefings.　　However, according to the reporter understand, in the Ministry of Health and other departments all-round "encirclement and suppression" of commercial bribery, some local health departments have been published on suspicion of commercial bribery list of pharmaceutical enterprises. Among them, the reporter was informed of a Beijing published materials show, because of suspected commercial bribery, Hebei, Connaught Pharmaceutical, Beijing million Funda and other enterprises have been driven out of Beijing market.　　However, the file was released earlier. Fujian Province, since 2006, has released four batches of 36 suspected commercial bribery enterprises.　　In addition, Sichuan, Hebei, Guangdong and other provinces have repeatedly published a number of suspected commercial bribery of pharmaceutical enterprises list. "In fact, in recent years, the packageSeveral departments, including the Ministry of Health, have made great efforts to combat commercial bribery. The health ministry officials said that since March 2006, in order to cope with the State Council's leading business bribery work, the medical system to regulate commercial bribery has begun. "Most of these cases were investigated before," he said.　　However, despite the high-pressure treatment, but since 2006, the medical field of commercial bribery has never stopped, and the enterprises involved in many small and medium-sized enterprises, large, foreign drug companies have rarely been investigated cases. Rumors of the alleged bribery of Johnson Zhang Salute may break foreign drug companies "safe and worry-free" situation. "It's unclear whether Johnson was involved in the Zhang Jing case," he said.　　"The National Drug Administration said to the official. In fact, foreign drug companies suspected of bribery has a precedent.　　2008, the United States Department of Justice provided information that, from 2003 to 2007, Siemens Medical Group paid about 14.4 million U.S. dollars of bribery, to 5 hospitals in China to pay bribes to obtain 295 million U.S. dollars in medical equipment orders. Chen Chenglong does said: "In fact, the problem is mostly foreign companies, large enterprises products, but these enterprises are certainly not a lot of investigation, their government public relations ability is stronger." Relatively speaking, the domestic small and medium-sized enterprises better deal with.　　"According to the Ministry of Health issued the notice, the provincial health Administrative department will establish a bad record of commercial bribery, once the enterprise is included, the provinces will resolutely cancel all of its products in the local bidding eligibility, within 2 years can not enter the province market." North China Pharmacy a regional marketing manager said: "With my sales experience, if a pharmaceutical factory really cannot sell its products in a province for two years, then it will be harder to rebuild the market trust two years from now, and the province market will be largely lost." "Drug companies bribe" undercurrent "bribery will always have its survival of the rotten soil."　　In fact, many pharmaceutical companies have come to the point where they cannot hit the market without paying bribes. Take medicine in hospital sales for example.　　After a lot of bribery won the bid, the enterprise does not mean that the product will be able to enter the hospital to sell smoothly, which also has to go to the threshold of the hospital darkened, the enterprise only to pay "buy road money" to allow products to enter the hospital. It is understood that in order to wipe out the obstacles, pharmaceutical enterprises, pharmaceutical enterprises in addition to direct bribery to the hospital, but also through various forms to the Doctor "rebate."　　Rebate items have "publicity fees", "advertising fees", "new product promotion fees", "foreign fees", "unified party fees" and so on. "Unified party Fee" is one of the more obvious commercial bribery. Drug Administration means that the hospital will each sale of drugs, according to the day, monthly sales statistics Summary, the formation of internal data, generally not published.　　In the hospital, the General party has the following several ways: The Doctor from the newspaper, pharmacy statistics, computer list and so on. But for enterprises, the data can reflect the drug sales of the enterprise, and then for the enterprise "promotional efforts" to make decisions for reference, it is particularly important.　　Drug companies, agents, medical representatives will be to doctors, pharmacies and other staff to pay the "unified party fees." "Unified party fee" has beenhas become one of the main forms of drug rebate, is generally a box of drugs in two or three cents, more than seven or eight cents per box or even a dollar.　　Although the rebate is not high, but involves more varieties, a wide range, a large number of pharmacies can be said to be "Hanlaobaoshou." A pharmaceutical enterprise related responsible person said, "The whole party fee is privately given, generally is to the related doctor, the pharmacy and the hospital computer room person." The production enterprise or the medicine that manages the enterprise to represent these people very familiar words, can obtain the enterprise in the hospital sale situation. "A domestic medical device Enterprise marketing department told reporters," to the cost of everyone is aware of the matter, medicine and medical equipment into the hospital no doubt to give kickbacks, no rebate products can not sell.　　"But the head of the medical device business marketing department said in contrast to the drug's cost, high value medical supplies do not have the cost, because the high value of medical supplies only specific hospital departments use, products sold to the hospital after the number of detailed, not like drugs, a number of departments prescribe, and a large quantity. In such a living environment, drug companies do not choose to bribe, which means suicide.